ANDA 86737, held by Kv Pharm. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 86737 (Cyproheptadine Hydrochloride), held by Kv Pharm, was first approved by FDA on Oct 14, 1980, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 14, 1980 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride4MG ยท tablet;oral | Cyproheptadine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters